Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Belal Al-Husein

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Cellular Physiology|April 6, 2013
Suppression of interactions between prostate tumor cell-surface integrin and endothelial ICAM-1 by simvastatin inhibits micrometastasisBelal Al-Husein, Anna Goc, Payaningal R Somanath
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Photolytic Controlled Release Formulation of Methotrexate Loaded in Chitosan/TiO<sub>2</sub> Nanoparticles for Breast CancerNusaiba Al-Nemrawi, Fatima Hameedat, Belal Al-Husein, et al.
Fundamental & Clinical Pharmacology|May 5, 2023
Rapid high performance liquid chromatography method for erlotinib quantification in vitro: Application to study the effect of resveratrol on metabolism and cellular uptake of erlotinibAref Zayed, Jomana Al Hroot, Abdulraouf Mayyas, et al.
Annals of Medicine and Surgery (2012)|May 27, 2021
Depression symptoms and quality of life in patients receiving renal replacement therapy in Jordan: A cross-sectional studySuhaib Muflih, Karem H Alzoubi, Sayer Al-Azzam, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 2010
Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expressionSamith T Kochuparambil, Belal Al-Husein, Anna Goc, et al.
Pharmacotherapy|December 5, 2012
Antiangiogenic therapy for cancer: an updateBelal Al-Husein, Maha Abdalla, Morgan Trepte, et al.
Expert Opinion on Therapeutic Targets|May 29, 2010
PAK1 as a therapeutic targetJulia V Kichina, Anna Goc, Belal Al-Husein, et al.
BMC Cancer|September 15, 2012
Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosisAnna Goc, Samith T Kochuparambil, Belal Al-Husein, et al.
International Journal of Oncology|November 27, 2010
PI3 kinase integrates Akt and MAP kinase signaling pathways in the regulation of prostate cancerAnna Goc, Belal Al-Husein, Samith T Kochuparambil, et al.
The Journal of Biological Chemistry|December 22, 2012
P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretionAnna Goc, Ahmad Al-Azayzih, Maha Abdalla, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Cellular Physiology|April 6, 2013
Suppression of interactions between prostate tumor cell-surface integrin and endothelial ICAM-1 by simvastatin inhibits micrometastasisBelal Al-Husein, Anna Goc, Payaningal R Somanath
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Photolytic Controlled Release Formulation of Methotrexate Loaded in Chitosan/TiO<sub>2</sub> Nanoparticles for Breast CancerNusaiba Al-Nemrawi, Fatima Hameedat, Belal Al-Husein, et al.
Fundamental & Clinical Pharmacology|May 5, 2023
Rapid high performance liquid chromatography method for erlotinib quantification in vitro: Application to study the effect of resveratrol on metabolism and cellular uptake of erlotinibAref Zayed, Jomana Al Hroot, Abdulraouf Mayyas, et al.
Annals of Medicine and Surgery (2012)|May 27, 2021
Depression symptoms and quality of life in patients receiving renal replacement therapy in Jordan: A cross-sectional studySuhaib Muflih, Karem H Alzoubi, Sayer Al-Azzam, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 2010
Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expressionSamith T Kochuparambil, Belal Al-Husein, Anna Goc, et al.
Pharmacotherapy|December 5, 2012
Antiangiogenic therapy for cancer: an updateBelal Al-Husein, Maha Abdalla, Morgan Trepte, et al.
Expert Opinion on Therapeutic Targets|May 29, 2010
PAK1 as a therapeutic targetJulia V Kichina, Anna Goc, Belal Al-Husein, et al.
BMC Cancer|September 15, 2012
Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosisAnna Goc, Samith T Kochuparambil, Belal Al-Husein, et al.
International Journal of Oncology|November 27, 2010
PI3 kinase integrates Akt and MAP kinase signaling pathways in the regulation of prostate cancerAnna Goc, Belal Al-Husein, Samith T Kochuparambil, et al.
The Journal of Biological Chemistry|December 22, 2012
P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretionAnna Goc, Ahmad Al-Azayzih, Maha Abdalla, et al.
Pageof 2